Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View Plans2-year trend showing gross, operating, and net profit margins
Shilpa Medicare Limited's net profit margin of 6.1% in FY2025 reflects thin profitability, with operating margin at 15.9% and gross margin at 68.1%.
In FY 2025, Shilpa Medicare Limited posted a gross margin of 68.1%, an operating margin of 15.9%, a net margin of 6.1%. Gross Margin = (Revenue - COGS) / Revenue; Operating Margin = EBIT / Revenue; Net Margin = Net Income / Revenue. Typical healthy ranges: Gross 20-40%, Operating 10-20%, Net 5-10%+. Consistent or improving margins indicate strong competitive positioning.
2-year trend showing revenue, gross profit, and net profit
Shilpa Medicare Limited's revenue grew 11.7% to 12.86B and net profit grew 145.6% to 782.93M YoY in FY2025, indicating healthy business momentum.
In FY 2025, Shilpa Medicare Limited's revenue grew by 11.7% year-over-year. Revenue is total income from operations. Gross Profit is revenue minus cost of goods. Net Profit is the bottom line after all expenses. Consistent growth across all three signals a healthy, expanding business.
2-year trend showing shareholder returns
Shilpa Medicare Limited's ROE of 3.3% in FY2025 indicates weak shareholder returns.
In FY 2025, Shilpa Medicare Limited reported an ROE of 3.3%. ROE = (Net Income / Shareholders' Equity) x 100. Measures how efficiently the company turns equity into profit. Above 15% is generally strong; above 25% is excellent. Very high ROE may signal high leverage — check alongside debt levels.
2-year trend comparing profitability with cash generation
Shilpa Medicare Limited's FCF/NI ratio of -1.42x in FY2025 indicates weak cash generation raising concerns about earnings quality.
In FY 2025, Shilpa Medicare Limited's free cash flow trailed net income. Free Cash Flow = Operating Cash Flow - Capital Expenditure. When FCF exceeds net income, it suggests high-quality, cash-backed earnings. Persistent gaps may indicate aggressive accounting or heavy capex needs.
2-year trend comparing profitability with cash from operations
Shilpa Medicare Limited's OCF/NI ratio of 1.69x in FY2025 indicates strong cash collection and working capital efficiency.
In FY 2025, Shilpa Medicare Limited's operating cash flow exceeded net income. Operating Cash Flow is the actual cash from core operations. OCF exceeding net income signals strong cash collection. OCF trailing net income may indicate aggressive revenue recognition or working capital issues.
Measure a company's financial leverage, liquidity, and ability to meet financial obligations.
2-year trend showing short-term liquidity position
Shilpa Medicare Limited's current ratio of 1.46x in FY2025 indicates healthy short-term liquidity.
In FY 2025, Shilpa Medicare Limited reported a current ratio of 1.46. Current Ratio = Current Assets / Current Liabilities. Measures short-term liquidity. A ratio of 1.5-3.0 is generally healthy; below 1.0 signals liquidity risk; above 3.0 may indicate underutilized assets.
2-year trend showing ability to service debt
Shilpa Medicare Limited's interest coverage ratio of 2.7x in FY2025 indicates acceptable but limited debt servicing headroom.
In FY 2025, Shilpa Medicare Limited reported an interest coverage ratio of 2.7x. Interest Coverage = EBIT / Interest Expense. Shows how many times operating profit covers interest payments. Above 5x is comfortable; below 1.5x signals potential difficulty servicing debt.
2-year trend showing financial leverage and capital structure
Shilpa Medicare Limited's debt-to-equity ratio of 0.25x in FY2025 reflects a conservative, low-leverage capital structure.
In FY 2025, Shilpa Medicare Limited reported a debt-to-equity ratio of 0.25. Debt-to-Equity = Total Debt / Total Equity. Below 1.0 is conservative; 1.0-2.0 is moderate; above 2.0 indicates higher financial risk. Capital-intensive industries naturally carry higher ratios.
2-year trend showing total debt with year-over-year changes
Shilpa Medicare Limited's debt decreased 37.3% YoY in FY2025 — positive deleveraging improves financial flexibility.
In FY 2025, Shilpa Medicare Limited's total debt decreased by 37.3% year-over-year. Total Debt includes short-term debt, long-term loans, debentures, and capital leases. YoY changes (shown as percentages) reveal whether the company is leveraging up or deleveraging.
Year-over-year change in diluted shares outstanding
Shilpa Medicare Limited's diluted shares increased 12.2% YoY in FY2025 — significant dilution that warrants concern.
Over 2 years (FY2024–FY2025), diluted shares increased 12.2% from 173.60M to 194.86M, indicating cumulative dilution.
In FY 2025, Shilpa Medicare Limited's diluted shares increased by 12.2% year-over-year. Diluted Shares accounts for stock options, warrants, and convertibles. Positive YoY change means dilution (red); negative means buybacks (green). Consistent dilution above 5% annually is a red flag.
You're viewing 2 years of data. Upgrade to access 10 years of financial ratios, margins, and performance metrics.
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2025